Why the study?
Does Interleukin-1beta increase the expression and activity of MMP-2 in cardiac microvascular endothelial cells?
Does Interleukin-1beta increase the expression and activity of MMP-2 in cardiac microvascular endothelial cells?
IL-1beta modulates the expression and activity of MMP-2 in cardiac microvascular endothelial cells via PKCalpha/beta1 and ERK1/2 signaling pathways, providing mechanistic insight into post-MI remodeling.
Answers are grounded in this paper and cite their sources.
May guide targeted studies of endothelial signaling in remodeling; leaves open translation beyond animal models.
Matrix metalloproteinases (MMPs), a family of extracellular endopeptidases, are implicated in angiogenesis because of their ability to selectively degrade components of the extracellular matrix. Interleukin-1beta (IL-1beta), increased in the heart post-myocardial infarction (post-MI), plays a protective role in the pathophysiology of left ventricular (LV) remodeling following MI. Here we studied expression of various angiogenic genes affected by IL-1beta in cardiac microvascular endothelial cells (CMECs) and investigated the signaling pathways involved in the regulation of MMP-2. cDNA array analysis of 96 angiogenesis-related genes indicated that IL-1beta modulates the expression of numerous genes, notably increasing the expression of MMP-2, not MMP-9. RT-PCR and Western blot analyses confirmed increased expression of MMP-2 in response to IL-1beta. Gelatin in-gel zymography and Biotrak activity assay demonstrated that IL-1beta increases MMP-2 activity in the conditioned media. IL-1beta activated ERK1/2, JNKs, and protein kinase C (PKC), specifically PKCalpha/beta(1), and inhibition of these cascades partially inhibited IL-1beta-stimulated increases in MMP-2. Inhibition of PKCalpha/beta(1) failed to inhibit ERK1/2. However, concurrent inhibition of PKCalpha/beta(1) and ERK1/2 almost completely inhibited IL-1beta-mediated increases in MMP-2 expression. Inhibition of p38 kinase and nuclear factor-kappaB (NF-kappaB) had no effect. Pretreatment with superoxide dismutase (SOD) mimetic, MnTMPyP, increased MMP-2 protein levels, whereas pretreatment with SOD and catalase mimetic, EUK134, partially inhibited IL-1beta-stimulated increases in MMP-2 protein levels. Exogenous H(2)O(2) significantly increased MMP-2 protein levels, whereas superoxide generation by xanthine/xanthine oxidase had no effect. This in vitro study suggests that IL-1beta modulates expression and activity of MMP-2 in CMECs.
No takes yet. Share an insight, caveat, or question.
Mountain et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: